I am Andrea Guida, a medical resident in Public Health at the University of Florence, currently rotating at the Epidemiology Unit of AUSL Reggio Emilia, where I am deepening my knowledge in the field of cancer screening.

Jim Peters is an epidemiologist and works as a postdoctoral researcher at the IQ Health department of Radboudumc. His research mainly focuses on breast cancer screening, prediction models, and artificial intelligence. He coordinates the PRISMA study, which has involved nearly 80,000 women. This study investigates the possibility of offering 'tailored screening' based on an individual's risk of breast cancer. Information about risk factors is available due to the collection of questionnaires, blood samples, and mammograms.

Charlotte is a computational biologist and postdoctoral researcher with a strong background in molecular microbiology and meta-omics, having earned her PhD from the University of Amsterdam in 2020. Her work within EUTOPS focuses on developing epigenetic cancer diagnostics, leveraging DNA methylation arrays, sequencing technologies, and real-time PCR data. Charlotte has a particular interest in the interplay between female cancer predisposition and the epigenome, exploring how aberrant hormone metabolism, the human microbiome, persistent HPV infections, and lifestyle factors contribute to disease risk and development.

Professor Mat Callister is a Respiratory Physician at Leeds Teaching Hospitals and an Honorary Professor of Respiratory Medicine at the University of Leeds. His research interest is the early diagnosis of lung cancer both through low-dose CT screening and symptomatic presentation. He is co-PI on studies in lung cancer screening (Yorkshire Lung Screening Trial), smoking cessation in screening programmes (YESS, YorQuit) and symptomatic early diagnosis (MEDLEY). He co-chaired the 2015 BTS Pulmonary Nodule Guideline, contributed to the UK NSC evaluation of lung cancer screening in 2020-2022, and is a member of the NHS England Lung Cancer Screening Expert Advisory Group.

Andrea Buron is medical doctor and specialist in preventive medicine and public health. She is head of the Cancer Prevention and Registry Unit in the Epidemiology and Evaluation Department of Hospital del Mar (Barcelona), coordinator of breast and colorectal cancer screening programmes, and lecturer at two universities (Universitat Pompeu Fabra and Universitat Central de Catalunya). As part of her training, she has spent several periods of time in UK, US and Germany. She has been actively involved in international and national public health related organizations. She has a special interest in ethics, public engagement and public speaking. (https://es.linkedin.com/in/andreaburonpust)

Paola Armaroli obtained Medical Degree, specialization in Hygiene and Preventive Medicine, School of Public Health, and a MSc in Epidemiology in the University of Turin, Italy. Since 2003 she is working in CPO-Piedmont, involved in several national and international independent epidemiological studies and trials on cancer screening. Member of the working groups on “EU cervical cancer screening guideline- supplements on HPV testing and HPV vaccination”, “European Code Against Cancer”, “European guidelines for Quality Assurance of Colorectal Cancer Screening”, in collaboration with the International Agency for Research on Cancer (IARC) (Lyon, France) and founded by the European Commission

Maija Vahteristo is a third year PhD student in the Finnish Cancer Registry, researching the benefits and harms of HPV screening. She also works with advancing the equity of the cancer screening programs and is a co-lead of EuCanScreen task on cancer screening of gender minorities.